Sture Larsson

Title: Innovator Sture Larsson: Pioneering Advances in Antibody Isolation

Introduction

Sture Larsson, an accomplished inventor based in Uppsala, Sweden, has made significant contributions to the field of biochemistry, particularly in antibody purification techniques. With a total of eight patents to his name, Larsson's work demonstrates a deep commitment to innovation in medical biotechnology.

Latest Patents

One of Sture Larsson's latest patents is titled "Chromatography ligand comprising domain C from protein A for antibody isolation." This invention centers on a chromatography ligand that contains Domain C from protein A (SpA) or a functional fragment or variant thereof. The chromatography ligand is designed to endure harsh cleaning in place (CIP) conditions while effectively binding Fab fragments of antibodies. It features a terminal coupling group, such as arginine or cysteine, which enables its attachment to an insoluble carrier, including beads or membranes. The processes associated with this ligand encompass antibody isolation and a comprehensive purification protocol, which may include washing steps and/or alkali regeneration.

Career Highlights

Sture Larsson has played pivotal roles in prominent biotechnology firms. He has notably worked with GE Healthcare Biosciences and Cytiva Bioprocess R&D, contributing his expertise to develop innovative solutions in protein purification and analysis.

Collaborations

Throughout his career, Larsson has collaborated with fellow professionals such as Martin Hall and Andreas Muranyi. These collaborations have enriched his research endeavors and have been instrumental in the successful development of his patented technologies.

Conclusion

Sture Larsson’s work stands as a testament to the power of innovation in the biotechnology sector. His contributions not only advance scientific understanding but also provide practical applications for antibody isolation, paving the way for improvements in therapeutic development and clinical practices.